Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Debt to Equity: 2020-2024

Historic Debt to Equity for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $25.95.

  • Oncology Institute's Debt to Equity fell 20499.55% to -$6.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.21, marking a year-over-year decrease of 20499.55%. This contributed to the annual value of $25.95 for FY2024, which is 160426.18% up from last year.
  • Oncology Institute's Debt to Equity amounted to $25.95 in FY2024, which was up 160426.18% from $1.52 recorded in FY2023.
  • In the past 5 years, Oncology Institute's Debt to Equity ranged from a high of $25.95 in FY2024 and a low of $0.0 during FY2021
  • Over the past 5 years, Oncology Institute's median Debt to Equity value was $0.65 (recorded in 2022), while the average stood at $5.71.
  • Its Debt to Equity has fluctuated over the past 5 years, first tumbled by 9958.61% in 2021, then skyrocketed by 3715386.37% in 2022.
  • Annual analysis of 5 years shows Oncology Institute's Debt to Equity stood at $0.42 in 2020, then crashed by 99.59% to $0.0 in 2021, then surged by 37153.86% to $0.65 in 2022, then surged by 132.63% to $1.52 in 2023, then surged by 1604.26% to $25.95 in 2024.
  • Its Debt to Equity stands at $25.95 for FY2024, versus $1.52 for FY2023 and $0.65 for FY2022.